Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial
Stavros Stavrakis(University of Oklahoma Health Sciences Center), Mary Beth Humphrey(Veterans Health Administration), Zain Ul Abideen Asad(University of Oklahoma Health Sciences Center), Khaled Elkholey(University of Oklahoma Health Sciences Center), Monika Niewiadomska(University of Oklahoma Health Sciences Center), Lynsie Morris(University of Oklahoma Health Sciences Center)
Cited by 101
Related Papers
Low-Level Transcutaneous Electrical Vagus Nerve Stimulation Suppresses Atrial Fibrillation
|Journal of the American College of Cardiology|2015|327
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
|Nature Genetics|2011|284
TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation)
|JACC. Clinical electrophysiology|2020|236
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
|JCI Insight|2016|226
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
|Circulation Arrhythmia and Electrophysiology|2019|222